19,432 followers
A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors: P-cadherin is a cell-cell adhesion molecule that is overexpressed in several solid.#immunology… https://t.co/